Condition: Interstitial Lung Disease (ILD) · Sponsor: Region Skane
The purpose of this study is to assess the effect of L-menthol on breathlessness and exercise capacity in patients with Interstitial lung disease (ILD).
This description comes directly from the study's public registry record.
Zainab Ahmadi, MD, PhD · 046171000 · zainab.ahmadi@med.lu.se
Always discuss trial participation with your own doctor first.
| Blekinge Institute of Technology | Karlskrona, Blekinge County, Sweden | Recruiting |
| Lund University hospital and Region Skåne | Lund, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07398287